John Macdonald, MD
Dr. John Macdonald serves as a Senior Advisor to AOC Oncology, and Senior Medical Advisor for Oncology for Criterium, Inc., a Clinical Research Organization. Dr. Macdonald served as Chief Medical Officer for Aptium Oncology for over ten years, where he was responsible for establishing and maintaining hospital and patient care quality and standards, as well as overseeing the company’s clinical research teams. A graduate of Harvard Medical School and trained in medical oncology at the National Cancer Institute, Macdonald is board-certified in internal medicine and medical oncology and served on the Oncology Subspecialty Committee of the American Board of Internal Medicine. This committee prepared the Medical Oncology subspecialty certification examination. An internationally recognized oncologist, Macdonald has authored over 600 articles, book chapters and abstracts.
Keri Reardon, RN, BSN, OCN, CCRP
Keri Reardon is a registered nurse with certifications in both oncology (OCN) and clinical research (CCRP). She has worked in the field of oncology clinical research for over 13 years. Starting out as a research nurse at the National Institutes of Health, Keri built her knowledge in Oncology and Clinical trials management. She later moved on to manage the Women’s Cancer Program for MedStar Health. After relocating to Los Angeles, she took a job at Cedars-Sinai and quickly moved into a management position overseeing the clinical operations for the Cancer Institute Clinical Research Office (CRO). Over the past 8+ years she has worked closely with the CRO and Cancer Center directors to build the hospital infrastructure necessary to apply for the NCI P30 Grant. This has included the development of research staffing models including the creation of new job titles/duties, workload management tools, creation of a research specimens processing lab, research SOPs, research pharmacy workflows, successful proposals for addition of new staff positions, and OnCore CTMS set up. Most recently Keri has focused her efforts on the development and roll-out of the research and Oncology modules in the EPIC EMR system.
Richard Emery MS, MBA, DABR
Richard Emery’s 20+ years of oncology experience covers a broad range of subjects including radiation therapy medical physics, in which Richard is certified by the American Board of Radiology; comprehensive cancer center design, construction, and implementation; hospital cancer center administration; oncology consulting; payer product design and development; and radiation oncology practice accreditation, where Richard was one of the American Society of Radiation Oncology’s original workgroup members for creating the new Accreditation Program for Excellence (APEx) and where Richard continues to actively serve APEx as both a committee member and surveyor. From 2010-2013, Richard worked as the Site Director of Administration at the Beth Israel Comprehensive Cancer Center West Side Campus, an 88,000 square foot facility in Manhattan. Previously, Richard was the Executive Director of the Trinitas Comprehensive Cancer Center, a position he held for 6 years. During this period, Richard also served as Vice President with Aptium Oncology. Richard received his MBA with honors from the Stern School of Business at New York University. Prior, Richard held leadership positions in Medical Physics, overseeing Radiation Oncology clinical practice, shielding design, and radiation safety. Richard earned his Masters of Science in Medical Physics from the University of Colorado Health Sciences Center.
Therica Miller MBA, CCRP, Executive Director, Research Administration & Operations
Therica Miller brings ten years of clinical research experience, with most of her career focused on managing large scale clinical trial offices. Her background in both industry and academic settings adds to her proficiency in clinical trial management. Her expertise includes regulatory affairs, research billing, research fiscal management (pre and post award activities), clinical trial system implementations, research infrastructure development and oncology research operations. Therica has served in a variety of clinical research operational positions, with a focus on building fiscally sound research programs. She is a member of several professional organizations including Association of Clinical Research Professionals (ACRP), Association of American Cancer Institutes (AACI) and Informatics for Cancer Centers (CI4CC) and leads research initiatives within such research organizations. Therica has collaborated with her network of colleagues to publish clinical trial administration and operations topics. Therica holds an MBA in Health Care Management and is a Certified Research Professional.
Jo Maranan
Jo Maranan is a marketer and communications strategist with more than 20 years experience in marketing communications, brand messaging and content marketing for both B2B and B2C markets. An award-winning copywriter, Jo transitioned from writing consumer ads to spearheading successful campaigns for healthcare products and services. As Director of Marketing Communications for Cardinal Health, a Fortune 20 healthcare company, Jo developed integrated marketing campaigns for a complex suite of nuclear medicine solutions. As Director of Marketing and Public Relations at Aptium Oncology, Jo launched advertising, marketing, PR and branding campaigns on both traditional and online media for the company’s oncology consulting and management services. Her portfolio includes ads, case studies, white papers and articles. Jo’s previous experience includes a stint as marketer and content developer for Response Genetics, a biotechnology company engaged in the research and development of molecular diagnostic tests for cancer, and as a change communications consultant for Saint Joseph Health.
Miriam Bischoff, MS, MBA
Miriam has more than 20 years of experience in management with a focus on oncology and clinical research. Prior to working with AOC, Miriam was the Executive Administrative Director, Clinical Research at the Stanford Cancer Institute (SCI). She joined SCI in 2003 to develop its centralized clinical research infrastructure in preparation for application for NCI designation, received in 2007, with comprehensive status awarded in 2016. Miriam was instrumental in developing SCI’s Clinical Trials Office and oversight committees. She led SCI’s efforts to identify and deploy a clinical trials management system (OnCore) along with programs to increase accrual to clinical trials. She has been active in national organizations focused on clinical research and NCI designated cancer centers including the American Association of Cancer Institutes (AACI) Clinical Research Initiative where she served on its initial steering committee. Prior to SCI, Miriam was a director in the biotechnology, medical device, and information systems industries, where she contributed to the development of clinical trial management applications, healthcare software, and oncology information systems. Miriam received her Master’s in Computer Science from Stanford University and an MBA from Golden Gate University.
Deane Wolcott, MD
From 2010-2015 Dr. Wolcott, was Director of Oncology Supportive Care Services for the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, in Los Angeles CA. From 1990-2009 he worked for Aptium Oncology in various roles, most recently as VP for Clinical Program Development. His primary responsibility was leading the development of comprehensive, multidisciplinary oncology supportive care and cancer pain management services at all Aptium Oncology managed Cancer Centers. He also served as Director of Business Development for Aptium Cancer Care, the Aptium Oncology UK subsidiary. He trained in adult psychiatry at the UCLA Neuropsychiatric Institute, and then stayed on the full time UCLA School of Medicine faculty from 1978-1990 providing psychiatric care to cancer and other serious chronically ill patient populations. His expertise is focused on helping hospital cancer programs provide comprehensive oncology supportive care services which meet national oncology patient-centered care quality standards. He is a distinguished life fellow of the American Psychiatric Association, and has been honored as a Fellow of the Academy of Psychosomatic Medicine and of the American Psychosocial Oncology Society.
Paul R. O'Dea
Paul R. O'Dea previously served as Vice-President of Hospital Business Development for McKesson Specialty Health, working closely with the US Oncology physician network. Formerly, he was Chief Operating Officer for Aptium Oncology, overseeing operations all of the company’s affiliated cancer centers. O’Dea was Executive Director of the Cedars-Sinai Outpatient Cancer Center the Samuel Oschin Comprehensive Cancer Institute for over 12 years. He also held the positions of Pharmacy Director for seven years and Associate Executive Director for one year. Prior to his career at Aptium Oncology, O'Dea held pharmacy positions with several prestigious health care institutions, including nine years with the University of California, Los Angeles (UCLA). He received his Bachelor of Science in Pharmacy from the University of Connecticut in 1969. O'Dea has published and presented extensively. He is also a member of numerous professional organizations including the Health Care Executives of Southern California, American College of Healthcare Executives, Association of Cancer Executives, and the Association of Community Cancer Centers.
William Guss PharmD, MBA, FCSHP
William Guss advises and assists clients on a broad range of matters, with particular focus on the safe, efficient, and cost-effective delivery of cancer drug treatments with an eye on future trends. Mr. Guss served as Vice President of Pharmacy Services for Aptium Oncology, where he developed expertise in oncology, pharmacy, clinical operations, technology, process improvement, and supply chain management to help drive operational excellence in cancer center operations for 20 years. Prior to joining Aptium, Mr. Guss was a pharmacy specialist at the UCLA Medical Center. He received his PharmD from the University of California at San Francisco and MBA from the Anderson Graduate School of Management at UCLA. He is a fellow of the California Society of Health-System Pharmacists.
.
2251 Pelham Ave Los Angeles CA 90064 us +1.323 697 8782 mbollinger@aoconcology.com
Contact Us
Michael J. Zeller, MPS
For the past 9 years, Michael Zeller served as the Senior Administrative Director of the NCI Designated Perlmutter Cancer Center at NYU Langone Health. During his tenure he was responsible for cancer center operations, expansion of the network to include seven regional sites and integration of the EPIC EMR suite of programs. Prior to joining NYU Langone Health Mr. Zeller was employed by Aptium Oncology as a VP/Executive Director. Mr. Zeller was involved with the design, construction and management of multiple hospital-based cancer centers in New York City and was the on-site Executive Director of the NYU Clinical Cancer Center. Prior to joining Aptium Oncology, Mr. Zeller was employed by Memorial Sloan-Kettering Cancer Center, New York for twenty years holding multiple administrative and financial executive positions. Mr. Zeller holds a Masters degree in Health Care Administration from Long Island University and his Bachelors of Arts degree in Political Science and Economics from Brooklyn College.